clinicalfraudoccurences.blogspot.com
Clinical Fraud Occurences: November 2005
http://clinicalfraudoccurences.blogspot.com/2005_11_01_archive.html
View my complete profile. How can Clinical Fraud Occur? Monday, November 28, 2005. How can Clinical Fraud Occur? By Patrick T. Busby. Ahsar, B.H., Miller, R.G., Getz, K.J., and Powe, N.R. (2004). Prevalence and determinants of physician participation in conducting pharmaceutical-sponsored clinical trials and lectures. Journal of General Internal Medicine, 19(11), 1140-1145. Http:/ www.fda.gov/ora/about/enf story/ch6 /oci2.htm. Accessed February 5, 2005. Http:/ strategis.ic.gc.ca/epic/internet...Mitchell,...
biopharmaceuticalindustrychallenges.blogspot.com
Biopharmaceutical Industry Challenges: Challenges Facing the Biopharmaceutical Industry
http://biopharmaceuticalindustrychallenges.blogspot.com/2005/11/challenges-facing-biopharmaceutical.html
View my complete profile. Tuesday, November 29, 2005. Challenges Facing the Biopharmaceutical Industry. Olatunji O. Ogunmefun, MBBS, MPH. Shortage of Appropriate Human Resources. Inability to Maximize Commercial Benefits. The industry is constrained to focus on research instead of bringing a product to market. Product rights are therefore usually licensed at an early stage with multinational pharmaceutical partners gaining most of the commercial benefits. Intellectual Property and Freedom to Operate.
outsourcingclinicalresearchfactors.blogspot.com
Considerations in Outsourcing Clinical Research: Key Considerations in Outsourcing Clinical Research
http://outsourcingclinicalresearchfactors.blogspot.com/2005/11/key-considerations-in-outsourcing.html
Considerations in Outsourcing Clinical Research. Monday, November 21, 2005. Key Considerations in Outsourcing Clinical Research. As presented by Dr.Jayashree, Officer Clinical Services, SPIC Pharma. Typical outsourcing issues that sponsors consider include: when to outsource; vendor selection; retaining in-house expertise; cost-effectiveness; patient recruitment; and regulatory and ethical issues. Do we have in-house resources? Are the resources available? Is it cost-effective to do the project in-house?
outsourcingclinicalresearchfactors.blogspot.com
Considerations in Outsourcing Clinical Research: November 2005
http://outsourcingclinicalresearchfactors.blogspot.com/2005_11_01_archive.html
Considerations in Outsourcing Clinical Research. Monday, November 21, 2005. Key Considerations in Outsourcing Clinical Research. As presented by Dr.Jayashree, Officer Clinical Services, SPIC Pharma. Typical outsourcing issues that sponsors consider include: when to outsource; vendor selection; retaining in-house expertise; cost-effectiveness; patient recruitment; and regulatory and ethical issues. Do we have in-house resources? Are the resources available? Is it cost-effective to do the project in-house?
informedconsentclinicaltrials.blogspot.com
Informed Consent in Clinical Trials: November 2005
http://informedconsentclinicaltrials.blogspot.com/2005_11_01_archive.html
Informed Consent in Clinical Trials. Monday, November 14, 2005. Participants in Clinical Trials and Informed Consent. Individuals taking part in clinical trials are not always patients in hospitals and institutions. Many are patients of private practitioners involved in clinical research. Other participants are not patients at all, but are healthy individuals who have been recruited for a study through a newspaper ad, poster, or other source. Please note this information does not give any medical advice.
biopharmaceuticalindustrychallenges.blogspot.com
Biopharmaceutical Industry Challenges: November 2005
http://biopharmaceuticalindustrychallenges.blogspot.com/2005_11_01_archive.html
View my complete profile. Challenges Facing the Biopharmaceutical Industry. Tuesday, November 29, 2005. Challenges Facing the Biopharmaceutical Industry. Olatunji O. Ogunmefun, MBBS, MPH. Shortage of Appropriate Human Resources. Inability to Maximize Commercial Benefits. Intellectual Property and Freedom to Operate. Nearly 80% of trials fail to enroll the required number of patients within the appropriate time frame. Any improvement in the pace of clinical trials - e.g. using the internet for...Biopharma...
clinicalfraudoccurences.blogspot.com
Clinical Fraud Occurences: How can Clinical Fraud Occur?
http://clinicalfraudoccurences.blogspot.com/2005/11/how-can-clinical-fraud-occur.html
View my complete profile. Monday, November 28, 2005. How can Clinical Fraud Occur? By Patrick T. Busby. Ahsar, B.H., Miller, R.G., Getz, K.J., and Powe, N.R. (2004). Prevalence and determinants of physician participation in conducting pharmaceutical-sponsored clinical trials and lectures. Journal of General Internal Medicine, 19(11), 1140-1145. Failure to report serious adverse events results in convictions. (2003). U.S. Food and Drug Administration, Available at. Accessed February 5, 2005. Mitchell, P&#...
informedconsentclinicaltrials.blogspot.com
Informed Consent in Clinical Trials: Participants in Clinical Trials and Informed Consent
http://informedconsentclinicaltrials.blogspot.com/2005/11/participants-in-clinical-trials-and.html
Informed Consent in Clinical Trials. Monday, November 14, 2005. Participants in Clinical Trials and Informed Consent. Individuals taking part in clinical trials are not always patients in hospitals and institutions. Many are patients of private practitioners involved in clinical research. Other participants are not patients at all, but are healthy individuals who have been recruited for a study through a newspaper ad, poster, or other source. Please note this information does not give any medical advice.
